{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:55:50Z","timestamp":1782924950037,"version":"3.54.5"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beckman-Coulter, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A new N-terminal pro\u2013B-type natriuretic peptide (NT-proBNP) immunoassay using de novo antibodies was developed on a DxI9000\u00a9 analyzer from Beckman. The aim of this study was to assess its analytical performance, and a comparison with the Elecsys-proBNPII assay from Roche was also performed. NT-proBNP values in healthy adults based on sex and age were established, and clinical performance in the diagnosis of chronic heart failure (CHF), acute heart failure (AHF), aging, and chronic kidney disease (CKD) populations was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analytical performance of the Access NT-proBNP assay was evaluated. A method comparison was performed using 200 fresh plasma samples as well as with all the patient samples included in the study (n = 531). The distribution of Access NT-proBNP levels in healthy subjects, patients with CHF or AHF, and patients with CKD was reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The total imprecision for NT-proBNP controls was 3.17% and 4.73%, and 3.70% and 10.45% in a plasma pool. The limit of blank and limit of detection were lower than those reported by the manufacturer. Correlation studies showed a good correlation between NT-proBNP measurements using the Access NT-proBNP assay and Roche analyzer.<\/jats:p>\n                    <jats:p>In a healthy population, the NT-proBNP concentrations increased across the age groups and significantly varied in healthy adult men and women throughout the years. In the different pathological situations studied, our results clearly demonstrated that the new NT-proBNP assay from Beckman meets European Society of Cardiology requirements for diagnostic approaches and monitoring of patients suspected of having chronic heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Access NT-proBNP assay showed acceptable analytical and diagnostic performance in heart failure. In cases of renal failure, our study encourages cautious interpretation of results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfag049","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:48:12Z","timestamp":1775130492000},"page":"709-722","source":"Crossref","is-referenced-by-count":0,"title":["Analytical and Clinical Performance Evaluation of a Novel NT-proBNP Assay with De Novo Antibodies across Different Population Groups"],"prefix":"10.1093","volume":"11","author":[{"given":"Anne Marie","family":"Dupuy","sequence":"first","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3235-3740","authenticated-orcid":false,"given":"Etienne","family":"Mondesert","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]},{"name":"PhyMedExp, Universit\u00e9 de Montpellier, INSERM, CNRS, Laboratoire de Biochimie et Hormonologie, CHU de Montpellier , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Margueritte","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Charif","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Morena","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]},{"name":"PhyMedExp, Universit\u00e9 de Montpellier, INSERM, CNRS, Laboratoire de Biochimie et Hormonologie, CHU de Montpellier , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Bargnoux","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]},{"name":"PhyMedExp, Universit\u00e9 de Montpellier, INSERM, CNRS, Laboratoire de Biochimie et Hormonologie, CHU de Montpellier , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[{"name":"PhyMedExp, Universit\u00e9 de Montpellier, INSERM, CNRS, Laboratoire de Biochimie et Hormonologie, CHU de Montpellier , Montpellier ,","place":["France"]},{"name":"D\u00e9partement de Cardiologie, Univ Montpellier 1 , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8563-7278","authenticated-orcid":false,"given":"Jean Paul","family":"Cristol","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Hormonologie, CHU Montpellier, Univ Montpellier 1 , Montpellier ,","place":["France"]},{"name":"PhyMedExp, Universit\u00e9 de Montpellier, INSERM, CNRS, Laboratoire de Biochimie et Hormonologie, CHU de Montpellier , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2026070109542877300_jfag049-B1","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026070109542877300_jfag049-B2","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026070109542877300_jfag049-B3","doi-asserted-by":"crossref","first-page":"102206","DOI":"10.1016\/j.jacadv.2025.102206","article-title":"A novel N-terminal pro-B-type natriuretic peptide assay in the early diagnosis of acute heart failure","volume":"4","author":"Belkin","year":"2025","journal-title":"JACC Adv"},{"key":"2026070109542877300_jfag049-B4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jalm\/jfaf012","article-title":"Analytical characterization and validation of a novel automated amino-terminal proB-type natriuretic peptide assay","volume":"10","author":"Christenson","year":"2025","journal-title":"J Appl Lab Med"},{"key":"2026070109542877300_jfag049-B5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/clinchem\/hvaf168","article-title":"Evaluation of a new antibody-based NT-proBNP assay for acute dyspnea in the emergency department","volume":"72","author":"Allen","year":"2026","journal-title":"Clin Chem"},{"key":"2026070109542877300_jfag049-B6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jacc.2018.01.021","article-title":"N-terminal pro-B-type natriuretic peptide in the emergency department: the ICON-RELOADED study","volume":"71","author":"Januzzi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026070109542877300_jfag049-B7","volume-title":"EP15-A3: User verification of precision and estimation of bias-approved guideline","author":"CLSI","year":"2014"},{"key":"2026070109542877300_jfag049-B8","volume-title":"EP17-A2: Protocols for determination of limits of detection and limits of quantitation","author":"CLSI","year":"2004"},{"key":"2026070109542877300_jfag049-B9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026070109542877300_jfag049-B10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"2026070109542877300_jfag049-B11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0895-4356(96)00011-X","article-title":"The meaning of kappa: probabilistic concepts of reliability and validity revisited","volume":"49","author":"Guggenmoos-Holzman","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"2026070109542877300_jfag049-B12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/diagnostics12051172","article-title":"Performance of the Abbott architect immuno-chemiluminometric NT-proBNP assay","volume":"12","author":"Lau","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026070109542877300_jfag049-B13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.5858\/arpa.2021-0587-OA","article-title":"Evaluation of analytical performances and comparison of 3 NT-proBNP assays for diagnosing heart failure","volume":"147","author":"Cho","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"2026070109542877300_jfag049-B14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12872-024-03994-w","article-title":"Analytical and clinical performance evaluation of a new NT-proBNP assay","volume":"24","author":"Feng","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"2026070109542877300_jfag049-B15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/ehf2.13834","article-title":"N-terminal pro brain natriuretic peptide reference values in community-dwelling older adults","volume":"9","author":"Braisch","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026070109542877300_jfag049-B16","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/ehf2.14894","article-title":"Setting the optimal threshold of NT-proBNP and BNP for the diagnosis of heart failure in patients over 75 years","volume":"11","author":"Berthelot","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026070109542877300_jfag049-B17","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC","volume":"25","author":"Bayes-Genis","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026070109542877300_jfag049-B18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"2026070109542877300_jfag049-B19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ejhf.612","article-title":"Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting","volume":"19","author":"Ibrahim","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026070109542877300_jfag049-B20","doi-asserted-by":"crossref","first-page":"e009427","DOI":"10.1161\/CIRCHEARTFAILURE.121.009427","article-title":"Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort","volume":"15","author":"Welsh","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2026070109542877300_jfag049-B21","doi-asserted-by":"crossref","first-page":"120249","DOI":"10.1016\/j.cca.2025.120249","article-title":"A novel NT-proBNP assay for heart failure diagnosis: a prospective, multicenter clinical trial","volume":"15","author":"Guidi","year":"2025","journal-title":"Clin Chim Acta"},{"key":"2026070109542877300_jfag049-B22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CN109480","article-title":"Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure","volume":"92","author":"Charmetant","year":"2019","journal-title":"Clin Nephrol"},{"key":"2026070109542877300_jfag049-B23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ejhf.3618","article-title":"Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC","volume":"27","author":"Skouri","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026070109542877300_jfag049-B24","doi-asserted-by":"crossref","first-page":"100517","DOI":"10.1016\/j.xkme.2022.100517","article-title":"Kidney function specific reference limits for N-terminal pro brain natriuretic peptide and high sensitivity troponin T: the systolic blood pressure intervention trial","volume":"4","author":"Bansal","year":"2022","journal-title":"Kidney Med"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/4\/709\/68186888\/jfag049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/4\/709\/68186888\/jfag049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:29:38Z","timestamp":1782923378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/4\/709\/8664881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,29]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfag049","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,4,29]]}}}